Met Met Proto Oncogene, Receptor Tyrosine Kinase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Met Met Proto Oncogene, Receptor Tyrosine Kinase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| MET Proto-Oncogene, Receptor Tyrosine Kinase | |
|---|---|
| Gene Symbol | MET |
| Full Name | MET Proto-Oncogene, Receptor Tyrosine Kinase |
| Chromosome | 7q31.2 |
| NCBI Gene ID | 4233 |
| OMIM | 164860 |
| Ensembl ID | ENSG00000105976 |
| UniProt ID | P08581 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Cancer, Pulmonary hypertension |
MET (c-Met) is the receptor for hepatocyte growth factor (HGF). It is a receptor tyrosine kinase involved in cell scattering, proliferation, and motility. MET is important for embryonic development, wound healing, and tissue regeneration[^1].
MET performs signaling functions:
MET implicated in AD:
In PD:
MET is expressed in:
Met Met Proto Oncogene, Receptor Tyrosine Kinase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Met Met Proto Oncogene, Receptor Tyrosine Kinase has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.